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coronary syndromesAccording to the World Health Organization, cardiovascular
disease is the main cause of death and is expected to cause
more than 23.6 million deaths till 2030.1 The incidence of
acute coronary syndromes (ACS) is lower in women than
men in all ages.2 While the overall cardiovascular mortality
is higher in men than women, this difference appears to be
eliminated in the last decade as men show a decrease with
corresponding female increased mortality associated with
coronary artery disease.3,4 However, the effect of the
acute myocardial infarction (AMI) in younger women5 has
increased and it may exhibit a higher risk of death
compared to young men.6 Generally women presented
more often with AMI without ST elevation (NSTE-ACS) or
unstable angina and less often with ST segment elevation
(STEMI) compared to men.7
From pathophysiological aspect the use of newer inva-
sive and noninvasive imaging techniques such as coronary
artery grayscale-IVUS, VH-IVUS, OCT showed differences in
acute coronary events between men and women.8 In
particular, women have smaller arteries9 and therefore
smaller plaque burden required for clot coronary disease
events and further may have a higher restenosis risk.10 In
addition, women have a lower plaque burden, compared to
males at all ages but culprit lesions are similar in OCT in
both sexes. Autopsy studies have shown that the erosion
compared to the plaque rupture is the principal mechanism
of coagulation and erosion occurs more often in younger
women.11 In women <65 years old the not culprit lesions
are fewer and with less focal atheromatosis and plaque
ruptures in relation to men, while the difference is
smoother after 65 years.12 Regarding the non-
atherosclerotic mechanisms of the ACS seems that women
have often microvascular and endothelial dysfunction
resulting in recurrent angina, hospitalizations and heart
failure.13
Women with acute myocardial infarction (AMI) with
elevation of the ST (STEMI) compared to men are older,Peer review under responsibility of Hellenic Cardiological
Society.
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arrive later at hospital2 where exhibit atypical symptoms
such as vomiting, breathlessness, neck pain, palpitations.2
Additionally women have more frequently angina or heart
failure, and worse Killip class and compare to men develop
often cardiogenic shock, pulmonary edema, sinus arrest,
stroke, mechanical complications and major bleeding
events even after statistical adjustment to age and
comorbidities. Instead men often exhibit malignant ven-
tricular arrhythmias and sudden cardiac death.2 When
women are diagnosed with STEMI receive less often proper
therapy since the era of thrombolysis14 including admission
into intensive care unit,15 aspirin and thrombolysis.16 Pri-
mary angioplasty which is the best method of revascular-
isation for both men and women accompanied by higher
rates of vascular complications in women.16,17 Younger
women with STEMI show higher rates of inhospital mortality
than men, even after adjusting for the medical history,
clinical severity and early treatment, while women <55
years old presented without chest pain show higher inhos-
pital mortality compared to men.18e20 Possible explana-
tions of the higher short-term mortality of young women
seem to be the highest pre-hospital mortality of men, most
cardiovascular risk factors, most comorbidities in women
with ACS, less typical symptoms and more doubtful di-
agnoses leading to suboptimal treatment, omission and
failure to recognize in time of the basis of the guidelines
symptoms and a lower percentage of treatments. As
regards the long-term survival although less studied ap-
pears that women have better results after STEMI compared
to men.21
Women with AMI without ST elevation (NSTE-ACS)
compared with men seem to have suboptimal treatment at
admission and after the hospital even though they have
increased cardiovascular risk and lack of differences in
guidelines.2 The role of gender on prognosis of patients
with NSTE-ACS is in doubt. Women have higher rates of non-
obstructive epicardial coronary disease, compared to men,
and this subpopulation shows better inhospital prognosis in
both sexes compared to patients with significantElsevier B.V. This is an open access article under the CC BY-NC-ND
President’s page 297atherosclerotic disease.22 Rather worse prognosis show
women with NSTE-ACS and significant epicardial coronary
disease after PCI.23 Overall, the data so far that determine
the differences in the prognosis of both sexes after NSTE-
ACS mainly based on statistical correlations, extent of
coronary disease and maybe in a different response to
antithrombotic therapeies.24 Kragholm et al showed the
reduced participation of women in clinical trials in patients
with NSTE-ACS in the absence of improvement in recent
years, while the treatments based on the instructions and
the prognosis has improved between women.25
Pharmaceutical treatment of AMI shows no difference in
efficacy between the two sexes. Beta blockers, statins,
angiotensin-converting enzyme inhibitors and antith-
rombotic therapy in several studies is the appropriate
evidence-based treatment of acute coronary syndromes. In
particular recent studies demonstrate similar efficacy of
anticoagulant therapy between two sexes.26 However fe-
male sex has been associated with increased bleeding risk27
among patients with ACS and features an important and
independent predictor of in-hospital major bleeding factor
in CRUSADE bleeding score.28,29 Nevertheless other studies
such as the ACUITY30 study do not revealed significant
interaction between gender antithrombotic treatment
haemorrhagic risk after one year, whereas studies such as
TRITON-TIMI 38,26 PLATO31 and CHAMPION PHOENIX32
revealed similar results. This distinction between observa-
tional studies and subpopulations analyzes of clinical
studies may be attributed to the reduced representation of
women in clinical studies with ACS.33 Another explanation
might be the antithrombotic treatment dosage which is not
adjusted on weight and renal function affecting mainly
women.26 Thus although women treated with the same
pharmacological antithrombotic treatments with men, a
closer monitoring by measuring body weight and creatinine
clearance and dose adjustment is needed.26
The non-occlusive atherosclerotic disease, defined as
<50% stenosis of the coronary vessel, is found in 5e20% of
ACS.34 In a recent study of patients with NSTE-ACS, the
total mortality was higher in patients without obstructive
coronary disease than obstructive, which was associated
with higher non-cardiac mortality and reinfarction and
unplanned revascularization was higher in patients with
obstructive coronary artery disease.35 An important cause
of non-obstructive atherosclerosis acute coronary syn-
drome is the Takotsubo cardiomyopathy associated with
2e5% ACS and referred mainly in postmenopausal women
after emotional or physical stress in> 80%.36
The automatic dissection of coronary arteries (sponta-
neous coronary artery dissection, SCAD) is also a major
cause of non-atherosclerotic coronary disease. It is a dis-
ease entity which is increasingly recognized as a common
cause of AMI in young women often underdiagnosed as a
cause of sudden cardiac death, ventricular tachyar-
rhythmia, STEMI and NSTE-ACS.37,38 The incidence of SCAD
is uncertain but according to retrospective studies based in
angiographic data ranges from 0.07 to 1.1%.39 The first
description of the disease was in 1931 by Dr Pretty who
described the sudden death of a 42years old female with
multi pregnancies after angina while the autopsy revealed
the dissection of the right coronary artery. More than 4% of
ACS and over 40% of ACS in women <55 years of age may bedue to automatic dissection of coronary artery.37 Disease
entities such as Marfan syndrome, systemic lupus erythe-
matosus, the perinatal period in> 25%, physical or
emotional stress> 55% and fibromuscular dysplasia of up to
70% associated with non-atherosclerotic automatic dissec-
tion of coronary arteries.40,41 Moreover they have been
reported familial cases according to the Mayo Clinic records
and multiple arteries attact.42 Various recurrence rates
have been reported by 13% at 2 years, up to 20% after 10
years in different patients registries.35,43 Younger imaging
techniques such as IVUS and OCT improve the diagnostic
imaging of the disease and may help to guide therapeutic
decisions.37 Angiographically includes three types 1) Multi-
ple lumens (true, psefdolumen) 2) Mild diffuse stenosis 3)
Imitates atherosclerosis.44 The therapeutic approach varies
leading some investigators to promote conservative treat-
ment compared with angioplasty in fragile coronary ar-
teries unless acute ischemia developed.37 In particular
based on the position that the vessels of SCAD can be
treated concervatively38,39 and in contrast with the treat-
ment of atherosclerotic coronary artery disease by inter-
ventional cardiology becoming increasingly adopting the
approach ’’ less is more ’’. Therefore avoid coronary
intervention in patients with stable SCAD with conserved
flow and even with significant blockage or infraction.41
However angioplasty or CABG remains the appropriate so-
lution in patients clinically unstable or with complete
obstruction, even in pregnant patients.41 The rate and
frequency of healing is not known. A significant percentage
of patients under conservative treatment may experience
disease progression and require revascularization requiring
more thorough clinical monitoring of patients during acute
phase.41 Automatic dissections of other vessels are quite
frequent and the risk of coronary angiography outweigh the
possible benefits. Although the short-and long-term prog-
nosis of these patients is good seems to remain the risk of
major cardiovascular events39 and would require contin-
uous monitoring with corresponding cardiovascular imaging
on clinical indications.
In conclusion, recognition and quality of care between
sexes is not the same in ischemic heart disease, the pres-
ence of pathophysiological and psychosocial differences
between sexes also appears to affect their prognosis after
acute coronary syndrome and required greater represen-
tation of women in clinical trials acute coronary syndromes.
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